Wollamide B [D-Orn6Orn]

General Information


DRACP ID  DRACP01856

Peptide Name   Wollamide B [D-Orn6Orn]

Sequence  NVlLWX

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Hep-G2 Hepatoblastoma Blastoma IC50=137.6 µM SRB assay Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Vero cells: IC50=73.2 µg/ml

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  NCB: Asn1<--->X6

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  l=D-Leu; X=Orn

Chiral  Mix



Physicochemical Information


Formula  C26H34N6O4

Absent amino acids  ACDEFGHIKMPQRSTY

Common amino acids  LNVWX

Mass  69396

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  3

Net charge  0

Boman Index  465

Hydrophobicity  60

Aliphatic Index  113.33

Half Life 
  /

Extinction Coefficient cystines  5500

Absorbance 280nm  1100

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29125222

Title  Total Synthesis and Antibacterial Study of Cyclohexapeptides Desotamide B, Wollamide B and Their Analogs

Doi 10.1002/cbdv.201700414

Year  2018

Literature 2

Pubmed ID 29431987

Title  Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B Analogs

Doi 10.1021/acscombsci.7b00189

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.